gabexate has been researched along with Acatalasemia in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, K | 1 |
| Ogata, M | 1 |
1 other study available for gabexate and Acatalasemia
| Article | Year |
|---|---|
Effect of a protease inhibitor on the stability of catalase in liver and blood from acatalasemic and normal mice.
Topics: Acatalasia; Animals; Catalase; Enzyme Stability; Gabexate; Hydrogen-Ion Concentration; Liver; Male; | 1991 |